Literature DB >> 17576393

An hepatitis B virus surface antigen specific single chain of variable fragment derived from a natural immune antigen binding fragment phage display library is specifically internalized by HepG2.2.15 cells.

W-H Wen1, W-J Qin, H Gao, J Zhao, L-T Jia, Q-H Liao, Y-L Meng, B-Q Jin, L-B Yao, S-Y Chen, A-G Yang.   

Abstract

Hepatitis B virus surface antigen (HBsAg), a specific antigen on the membrane of hepatitis B virus (HBV)-infected cells, provides a perfect target for therapeutic drugs. In order to mediate successful targeted delivery of these therapies, it is essential to have antibodies that recognize HBsAg with high specificity and affinity. In this report, we constructed a natural immune antigen binding fragments (Fab) antibody phage display library against HBsAg and after three rounds of panning, five Fab fragments with significant HBsAg binding ability were selected and analysed. DNA sequencing revealed that all the light chains had the same sequence, while all the Fd genes exhibited different sequences. For further application, all of the Fab antibodies were reconstructed into single chain antibodies (scFvs) and expressed in Escherichia coli BL21 cells. Indirect enzyme-linked immunosorbent assay analysis demonstrated that all five scFvs maintained a high affinity for HBsAg and could bind HBsAg on the membrane of HBV-infected cells. Indirect fluorescent staining analysis revealed that one of the scFvs (scFv15) could be internalized into HBsAg-positive HepG2.2.15 cells through clathrin-mediated endocytosis pathway. The internalizing scFv15 antibody would have great potential for the targeted delivery of therapeutics to HBV-infected cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17576393     DOI: 10.1111/j.1365-2893.2007.00843.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  7 in total

Review 1.  Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.

Authors:  Johnny X Huang; Sharon L Bishop-Hurley; Matthew A Cooper
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

Review 2.  Bacteriophages and medical oncology: targeted gene therapy of cancer.

Authors:  Babak Bakhshinejad; Marzieh Karimi; Majid Sadeghizadeh
Journal:  Med Oncol       Date:  2014-07-11       Impact factor: 3.064

3.  Identification of HBsAg-specific antibodies from a mammalian cell displayed full-length human antibody library of healthy immunized donor.

Authors:  Chang-Zheng Li; Zhong-Kun Liang; Zhen-Rui Chen; Hai-Bo Lou; Ye Zhou; Zhe-Huan Zhang; Fei Yu; Shuwen Liu; Yuanping Zhou; Shuguang Wu; Wenling Zheng; Wanlong Tan; Shibo Jiang; Chen Zhou
Journal:  Cell Mol Immunol       Date:  2011-12-19       Impact factor: 11.530

Review 4.  Bacteriophages and their applications in the diagnosis and treatment of hepatitis B virus infection.

Authors:  Babak Bakhshinejad; Majid Sadeghizadeh
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

5.  Characteristics Peripheral Blood IgG and IgM Heavy Chain Complementarity Determining Region 3 Repertoire before and after Immunization with Recombinant HBV Vaccine.

Authors:  Long Ma; Xiaomei Wang; Xiaoying Bi; Jiezuan Yang; Bin Shi; Xiaoyan He; Rui Ma; Qingqing Ma; Xinsheng Yao
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

6.  Production and characterization of a recombinant single-chain antibody against Hantaan virus envelop glycoprotein.

Authors:  Jie Yang; Rui Chen; Junxia Wei; Fanglin Zhang; Yong Zhang; Lintao Jia; Yan Yan; Wen Luo; Yunxin Cao; Libo Yao; Jifeng Sun; Zhikai Xu; Angang Yang
Journal:  Appl Microbiol Biotechnol       Date:  2009-12-10       Impact factor: 4.813

Review 7.  Infectious disease antibodies for biomedical applications: A mini review of immune antibody phage library repertoire.

Authors:  Jing Yi Lai; Theam Soon Lim
Journal:  Int J Biol Macromol       Date:  2020-07-08       Impact factor: 6.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.